Published in Biochem Biophys Res Commun on November 30, 1992
Targeting MET in cancer: rationale and progress. Nat Rev Cancer (2012) 6.43
Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752. Proc Natl Acad Sci U S A (2006) 5.23
MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib. J Clin Oncol (2011) 3.27
MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients. Ann Oncol (2008) 2.28
Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis. Neuro Oncol (2005) 2.24
Durable complete response of metastatic gastric cancer with anti-Met therapy followed by resistance at recurrence. Cancer Discov (2011) 2.22
Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. Proc Natl Acad Sci U S A (1997) 2.12
An overview of the c-MET signaling pathway. Ther Adv Med Oncol (2011) 1.95
Cellular and molecular aspects of gastric cancer. World J Gastroenterol (2006) 1.84
c-MET as a potential therapeutic target and biomarker in cancer. Ther Adv Med Oncol (2011) 1.81
Carcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemoprevention. World J Gastrointest Oncol (2012) 1.74
MET: a promising anticancer therapeutic target. Nat Rev Clin Oncol (2012) 1.71
MET expression and amplification in patients with localized gastric cancer. Cancer Epidemiol Biomarkers Prev (2011) 1.42
MET in gastric carcinomas: comparison between protein expression and gene copy number and impact on clinical outcome. Br J Cancer (2012) 1.39
MET as a target for treatment of chest tumors. Lung Cancer (2008) 1.29
Phase II study evaluating 2 dosing schedules of oral foretinib (GSK1363089), cMET/VEGFR2 inhibitor, in patients with metastatic gastric cancer. PLoS One (2013) 1.28
RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma. Cancer Biol Ther (2011) 1.26
Hepatocyte growth factor/scatter factor-induced intracellular signalling. Int J Exp Pathol (2000) 1.22
Deep sequencing of gastric carcinoma reveals somatic mutations relevant to personalized medicine. J Transl Med (2011) 1.21
C-Met as a prognostic marker in gastric cancer: a systematic review and meta-analysis. PLoS One (2013) 1.16
The clinicopathologic association of c-MET overexpression in Iranian gastric carcinomas; an immunohistochemical study of tissue microarrays. Diagn Pathol (2012) 1.14
Targeting MET Amplification as a New Oncogenic Driver. Cancers (Basel) (2014) 1.11
MET amplification as a potential therapeutic target in gastric cancer. Oncotarget (2013) 1.09
MET phosphorylation predicts poor outcome in small cell lung carcinoma and its inhibition blocks HGF-induced effects in MET mutant cell lines. Br J Cancer (2011) 1.06
A novel multipurpose monoclonal antibody for evaluating human c-Met expression in preclinical and clinical settings. Appl Immunohistochem Mol Morphol (2009) 1.06
Overexpression of the hepatocyte growth factor (HGF) receptor (Met) and presence of a truncated and activated intracellular HGF receptor fragment in locally aggressive/malignant human musculoskeletal tumors. Am J Pathol (2000) 1.04
Prognostic significance of MET amplification and expression in gastric cancer: a systematic review with meta-analysis. PLoS One (2014) 1.03
p53 mutation pattern and expression of c-erbB2 and c-met in gastric cancer: relation to histological subtypes, Helicobacter pylori infection, and prognosis. Dig Dis Sci (2002) 1.02
Up-regulation of cytoskeletal-associated protein 2 in primary human gastric adenocarcinomas. J Cancer Res Clin Oncol (2003) 0.99
Emerging molecular targets in oncology: clinical potential of MET/hepatocyte growth-factor inhibitors. Onco Targets Ther (2014) 0.97
Increase in the circulating level of hepatocyte growth factor in gastric cancer patients. Br J Cancer (1997) 0.95
Heat-shock protein 27 (HSP27, HSPB1) is up-regulated by MET kinase inhibitors and confers resistance to MET-targeted therapy. FASEB J (2014) 0.93
Activating MET kinase rearrangements in melanoma and Spitz tumours. Nat Commun (2015) 0.92
Met is the most frequently amplified gene in endometriosis-associated ovarian clear cell adenocarcinoma and correlates with worsened prognosis. PLoS One (2013) 0.91
A c-Met inhibitor increases the chemosensitivity of cancer stem cells to the irinotecan in gastric carcinoma. Br J Cancer (2013) 0.91
Involvement of hepatocyte growth factor in increased integrin expression on HepG2 cells triggered by adhesion to endothelial cells. Br J Cancer (1997) 0.90
Differential roles of STAT3 depending on the mechanism of STAT3 activation in gastric cancer cells. Br J Cancer (2011) 0.90
Tyrosine-kinase expression profiles in human gastric cancer cell lines and their modulations with retinoic acids. Br J Cancer (2003) 0.88
DNA methylation and carcinogenesis in digestive neoplasms. World J Gastroenterol (1998) 0.87
How prognostic and predictive biomarkers are transforming our understanding and management of advanced gastric cancer. Oncologist (2014) 0.85
Chromosome band 16q24 is frequently deleted in human gastric cancer. Br J Cancer (1999) 0.84
Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplification. BMC Cancer (2016) 0.84
Recurrent chromosomal rearrangements at bands 8q24 and 11q13 in gastric cancer as detected by multicolor spectral karyotyping. World J Gastroenterol (2005) 0.82
Individualized treatment of gastric cancer: Impact of molecular biology and pathohistological features. World J Gastrointest Oncol (2015) 0.81
Genetic susceptibility on CagA-interacting molecules and gene-environment interaction with phytoestrogens: a putative risk factor for gastric cancer. PLoS One (2012) 0.81
Establishment of clival chordoma cell line MUG-CC1 and lymphoblastoid cells as a model for potential new treatment strategies. Sci Rep (2016) 0.79
Gelsolin-mediated activation of PI3K/Akt pathway is crucial for hepatocyte growth factor-induced cell scattering in gastric carcinoma. Oncotarget (2016) 0.79
Understanding and Targeting MET Signaling in Solid Tumors - Are We There Yet? J Cancer (2016) 0.79
Quantitative proteomics discloses MET expression in mitochondria as a direct target of MET kinase inhibitor in cancer cells. Mol Cell Proteomics (2010) 0.79
Novel DNA amplification on chromosomes 2p25.3 and 7q11.23 in cholangiocarcinoma identified by arbitrarily primed polymerase chain reaction. J Cancer Res Clin Oncol (2005) 0.79
Epigenetic regulation of DNA repair machinery in Helicobacter pylori-induced gastric carcinogenesis. World J Gastroenterol (2015) 0.78
Genetic mutation analysis of human gastric adenocarcinomas using ion torrent sequencing platform. PLoS One (2014) 0.78
Gastric cancer associated with overexpression of parathyroid hormone-related peptide (PTHrP) and PTH/PTHrP receptor in relation to tumor progression. J Gastroenterol (1997) 0.78
Helicobacter pylori induces cancer cell motility independent of the c-Met receptor. J Carcinog (2009) 0.78
Analysis of MET mRNA expression in gastric cancers using RNA in situ hybridization assay: its clinical implication and comparison with immunohistochemistry and silver in situ hybridization. PLoS One (2014) 0.78
Resistance to the c-Met inhibitor KRC-108 induces the epithelial transition of gastric cancer cells. Oncol Lett (2015) 0.78
Localization of Hepatocyte Growth Factor and Its Receptor met in Endocrine Cells and Related Tumors of the Gut and Pancreas: An Immunohistochemical Study. Endocr Pathol (2000) 0.77
Saracatinib impairs the peritoneal dissemination of diffuse-type gastric carcinoma cells resistant to Met and fibroblast growth factor receptor inhibitors. Cancer Sci (2014) 0.76
Biomarker development in MET-targeted therapy. Oncotarget (2016) 0.76
Novel c-Met inhibitor suppresses the growth of c-Met-addicted gastric cancer cells. BMC Cancer (2016) 0.76
Induction of c-met proto-oncogene expression at the metastatic site. Clin Exp Metastasis (1999) 0.75
Alterative expression of the collagenase and adhesion molecules in the highly metastatic clones of human colonic cancer cell lines. Clin Exp Metastasis (1998) 0.75
Molecular heterogeneity in the novel fusion gene APIP-FGFR2: Diversity of genomic breakpoints in gastric cancer with high-level amplifications at 11p13 and 10q26. Oncol Lett (2016) 0.75
Transformation of intact yeast cells treated with alkali cations. J Bacteriol (1983) 100.26
Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci U S A (1999) 14.90
Molecular characterization of an enterobacterial metallo beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob Agents Chemother (1994) 8.64
THE ETIOLOGY, MODE OF INFECTION, AND SPECIFIC THERAPY OF WEIL'S DISEASE (SPIROCHAETOSIS ICTEROHAEMORRHAGICA). J Exp Med (1916) 8.21
PCR detection of metallo-beta-lactamase gene (blaIMP) in gram-negative rods resistant to broad-spectrum beta-lactams. J Clin Microbiol (1996) 6.68
Solid phase synthesis of polynucleotides. VI. Further studies on polystyrene copolymers for the solid support. Nucleic Acids Res (1982) 6.38
A novel integron-like element carrying the metallo-beta-lactamase gene blaIMP. Antimicrob Agents Chemother (1995) 6.00
Chromosomal beta-lactamase of Klebsiella oxytoca, a new class A enzyme that hydrolyzes broad-spectrum beta-lactam antibiotics. Antimicrob Agents Chemother (1989) 5.98
Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ (2004) 5.49
Multifocal outbreaks of metallo-beta-lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum beta-lactams, including carbapenems. Antimicrob Agents Chemother (1996) 5.36
Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res (1995) 4.84
Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species. J Biol Chem (1999) 4.38
PI3K-Akt pathway: its functions and alterations in human cancer. Apoptosis (2004) 4.33
THE PROPHYLAXIS OF WEIL'S DISEASE (SPIROCHAETOSIS ICTEROHAEMORRHAGICA). J Exp Med (1916) 4.33
Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity. Nature (1988) 3.99
THE RAT AS A CARRIER OF SPIROCHAETA ICTEROHAEMORRHAGIAE, THE CAUSATIVE AGENT OF WEIL'S DISEASE (SPIROCHAETOSIS ICTEROHAEMORRHAGICA). J Exp Med (1917) 3.80
Cloning and expression in Escherichia coli of the gene for human tumour necrosis factor. Nature (1985) 3.59
THE SERUM TREATMENT OF WEIL'S DISEASE (SPIROCHAETOSIS ICTEROHAEMORRHAGICA). J Exp Med (1916) 3.24
Molecular epidemiologic evidence for association of thermostable direct hemolysin (TDH) and TDH-related hemolysin of Vibrio parahaemolyticus with gastroenteritis. Infect Immun (1990) 3.17
Characterization of a plasmid-borne and constitutively expressed blaMOX-1 gene encoding AmpC-type beta-lactamase. Gene (1994) 3.08
IL-6 is required for the development of Th1 cell-mediated murine colitis. J Immunol (2000) 3.08
Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet (1998) 3.01
Studies on the mass receptor potential of the isolated frog retina. II. On the basis of the ionic mechanism. Vision Res (1969) 2.91
Adenocarcinoma arising from a gastric duplication cyst with invasion to the stomach: a case report with literature review. J Clin Pathol (2004) 2.69
Effects of the complete removal of basic amino acid residues from the signal peptide on secretion of lipoprotein in Escherichia coli. J Biol Chem (1983) 2.66
Mechanism of action of quinolones against Escherichia coli DNA gyrase. Antimicrob Agents Chemother (1993) 2.48
Genomic organization of the Klebsiella pneumoniae cps region responsible for serotype K2 capsular polysaccharide synthesis in the virulent strain Chedid. J Bacteriol (1995) 2.47
Chlorophyll a oxygenase (CAO) is involved in chlorophyll b formation from chlorophyll a. Proc Natl Acad Sci U S A (1998) 2.35
Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry. Virology (2000) 2.33
Clinicopathologic features and endoscopic treatment of superficially spreading colorectal neoplasms larger than 20 mm. Gastrointest Endosc (2001) 2.30
Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res (1994) 2.29
A large family of class III plant peroxidases. Plant Cell Physiol (2001) 2.21
Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nat Med (2000) 2.16
Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer. Arch Surg (1997) 2.01
Differential inhibition of calpain and proteasome activities by peptidyl aldehydes of di-leucine and tri-leucine. J Biochem (1996) 2.00
Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer. Clin Cancer Res (1996) 2.00
Formation of the male-specific muscle in female Drosophila by ectopic fruitless expression. Nat Cell Biol (2000) 1.99
Studies on the mass receptor potential of the isolated frog retina. I. General properties of the response. Vision Res (1969) 1.97
Induction of the p16INK4a senescence gene as a new therapeutic strategy for the treatment of rheumatoid arthritis. Nat Med (1999) 1.95
Nosocomial spread of cephem-resistant Escherichia coli strains carrying multiple Toho-1-like beta-lactamase genes. Antimicrob Agents Chemother (1997) 1.84
Evaluation of the therapeutic effect of radiotherapy on cervical cancer using magnetic resonance imaging. Int J Radiat Oncol Biol Phys (1999) 1.82
[Red free light magnifying photography in neuritis and some retinal vascular lesions]. Nihon Ganka Kiyo (1969) 1.81
Somatic mutation of the APC gene in gastric cancer: frequent mutations in very well differentiated adenocarcinoma and signet-ring cell carcinoma. Hum Mol Genet (1992) 1.76
Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg (2002) 1.75
Expression of interleukin-8 correlates with vascularity in human gastric carcinomas. Am J Pathol (1998) 1.75
Arachidonic acid metabolites as intracellular modulators of the G protein-gated cardiac K+ channel. Nature (1989) 1.74
Characterization of pyridoxine auxotrophs of Escherichia coli: serine and pdxF mutants. J Bacteriol (1970) 1.72
A role for reactive oxygen species in endothelial cell anoikis. Circ Res (1999) 1.69
Platelet-derived endothelial cell growth factor in human colon cancer angiogenesis: role of infiltrating cells. J Natl Cancer Inst (1996) 1.69
Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase. Oncogene (2010) 1.68
Expression of epidermal growth factor receptor in human gastric and colonic carcinomas. Cancer Res (1988) 1.67
CIRCULATING IMMUNITY PRINCIPLES IN RAT-BITE FEVER. J Exp Med (1917) 1.64
Influenza A virus can undergo multiple cycles of replication without M2 ion channel activity. J Virol (2001) 1.63
Resection of hepatic and pulmonary metastases in patients with colorectal carcinoma. Cancer (1998) 1.62
Vascular endothelial growth factor secreted by replicating hepatocytes induces sinusoidal endothelial cell proliferation during regeneration after partial hepatectomy in rats. J Hepatol (2001) 1.62
Frequent replication errors at microsatellite loci in tumors of patients with multiple primary cancers. Cancer Res (1994) 1.61
A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. The Japanese Pediatric IgA Nephropathy Treatment Study Group. J Am Soc Nephrol (1999) 1.60
Identification of species and capsular types of Klebsiella clinical isolates, with special reference to Klebsiella planticola. Microbiol Immunol (1989) 1.60
Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res (1995) 1.60
Systematic review and meta-analysis: importance of CagA status for successful eradication of Helicobacter pylori infection. Aliment Pharmacol Ther (2006) 1.60
Molecular mechanism of stomach carcinogenesis. J Cancer Res Clin Oncol (1993) 1.60
Functional importance of the coiled-coil of the Ebola virus glycoprotein. J Virol (2000) 1.59
SPIROCHAETA HEBDOMADIS, THE CAUSATIVE AGENT OF SEVEN DAY FEVER (NANUKAYAMI) : FIRST PAPER. J Exp Med (1918) 1.59
Effective hepatic artery chemoembolization for advanced hepatocellular carcinoma with extensive tumour thrombus through the hepatic vein. J Gastroenterol Hepatol (1999) 1.59
Cyclin A/cdk2 activation is involved in hypoxia-induced apoptosis in cardiomyocytes. Circ Res (2001) 1.57
Persistently increased serum concentrations of cardiac troponin t in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes. Circulation (2001) 1.56
Effect of heat stress on muscle sympathetic nerve activity in humans. J Auton Nerv Syst (1997) 1.55
Effect of angina pectoris on myocardial protection in patients with reperfused anterior wall myocardial infarction: retrospective clinical evidence of "preconditioning". J Am Coll Cardiol (1995) 1.54
Clinicopathological features of gastric mucosa-associated lymphoid tissue lymphoma: a comparison with diffuse large B-cell lymphoma without a mucosa-associated lymphoid tissue lymphoma component. J Gastroenterol Hepatol (2001) 1.53
Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis. Cancer Genet Cytogenet (1997) 1.52
A severe outbreak of haemorrhagic colitis and haemolytic uraemic syndrome associated with Escherichia coli O157:H7 in Japan. Eur J Pediatr (1994) 1.52
Optimal walking in terms of variability in step length. J Orthop Sports Phys Ther (1997) 1.52
Use of a split dura for revascularization of ischemic hemispheres in moyamoya disease. J Neurosurg (1996) 1.52
Benefits and limits of hepatic resection for gastric metastases. Am J Surg (2001) 1.52
Evaluation of preserved urinary red blood cells by light microscopy. Clin Nephrol (1997) 1.48
Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human urothelial carcinomas. J Urol (1998) 1.48
Serum interleukin-6 level reflects the tumor proliferative activity in patients with colorectal carcinoma. Cancer (1999) 1.48
Aggressive surgical approaches to hilar cholangiocarcinoma: hepatic or local resection? Surgery (1998) 1.47
Epigenetic heterogeneity at imprinted loci in normal populations. Biochem Biophys Res Commun (2001) 1.47
Hepatic resection for colorectal metastases: analysis of prognostic factors. Dis Colon Rectum (1999) 1.46
Effect of pH on activities of novel beta-lactamases and beta-lactamase inhibitors against these beta-lactamases. Antimicrob Agents Chemother (1995) 1.46
Focal adhesion kinase gene silencing promotes anoikis and suppresses metastasis of human pancreatic adenocarcinoma cells. Surgery (2004) 1.45
Aggressive surgical resection for hepatic metastases involving the inferior vena cava. Am J Surg (1999) 1.44
Clinicopathological significance of vascular endothelial growth factor (VEGF)-C in human esophageal squamous cell carcinomas. Int J Cancer (2001) 1.44
Immunolocalization of an inwardly rectifying K+ channel, K(AB)-2 (Kir4.1), in the basolateral membrane of renal distal tubular epithelia. FEBS Lett (1996) 1.44
Wide distribution of [3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis (1998) 1.44
Essential hypertension and neurovascular compression at the ventrolateral medulla oblongata: MR evaluation. AJNR Am J Neuroradiol (1995) 1.43
Identification of recurrent chromosomal rearrangements and the unique relationship between low-level amplification and translocation in glioblastoma. Genes Chromosomes Cancer (2001) 1.43
Chordoid meningioma in a child. Case report. J Neurosurg (1998) 1.43
Surgical management of cervicomedullary compression in achondroplasia. Childs Nerv Syst (1996) 1.43
Two isoforms of a chloride channel predominantly expressed in thick ascending limb of Henle's loop and collecting ducts of rat kidney. J Biol Chem (1994) 1.42
Relationship between number of asbestos bodies in autopsy lung and pleural plaques on chest X-ray film. Chest (1989) 1.42
Snail-associated epithelial-mesenchymal transition promotes oesophageal squamous cell carcinoma motility and progression. J Pathol (2008) 1.42
Diffusion anisotropy measurement of brain white matter is affected by voxel size: underestimation occurs in areas with crossing fibers. AJNR Am J Neuroradiol (2007) 1.42